Rare diseases
Investigational molecules
Locations
213 conditions with trials, the busiest first
505 trials across Europe, recruiting first
A Study of Long-Term Safety of Teplizumab in Children and Adolescents with Recently Diagnosed Type 1 Diabetes
BelgiumStudy of Ramucirumab and Dacarbazine for Patients with Progressive Metastatic Pancreatic Neuroendocrine Tumors
GermanyStudy of Nivolumab with Chemotherapy for Children and Teenagers with Refractory or Relapsing Solid Tumors or Lymphoma
FranceStudy on Metyrapone for Patients with Mild Autonomous Cortisol Secretion Due to Adrenal Adenoma
AustriaStudy of AdVince (Modified Adenovirus) Treatment Through Hepatic Artery Injection in Patients with Advanced Neuroendocrine Neoplasms
SwedenStudy on the Effectiveness of ODM-111 and Paracetamol for Chronic Pain in Patients with Diabetic Peripheral Neuropathy
BulgariaStudy of Cabozantinib in Adults with Progressive Thyroid Cancer Who Did Not Respond to Previous Treatment with Radioactive Iodine and VEGFR Therapy
PolandStudy on the Effects of Leriglitazone for Adult Men with Cerebral Adrenoleukodystrophy
FranceStudy on Ixekizumab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients
SwedenStudy of durvalumab, carboplatin and etoposide combination therapy for patients with metastatic large-cell neuroendocrine lung cancer who have not received previous treatment
ItalyStudy on Slowing Advanced Puberty in Girls Using Metformin, Pioglitazone, and Spironolactone
SpainStudy on the Safety and Tolerability of VRDN-001 for Patients with Thyroid Eye Disease
FranceThe therapies tested most often in Endocrine disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
